Peng

CORRECTION - Lancaster Resources to Spin-Off Nelson Lake through Plan of Arrangement

Retrieved on: 
Tuesday, January 30, 2024

Full details of the Spin-Off, Nelson Lake, and the Nelson Lake Copper Project will be included in an information circular which will be distributed to Lancaster shareholders in advance of the Meeting.

Key Points: 
  • Full details of the Spin-Off, Nelson Lake, and the Nelson Lake Copper Project will be included in an information circular which will be distributed to Lancaster shareholders in advance of the Meeting.
  • Pursuant to the Arrangement Agreement, the parties have agreed to a Plan of Arrangement whereby Lancaster will issue 550,000 Lancaster common shares with a deemed value of $0.06 each to Nelson Lake in exchange for 1,650,000 Nelson Lake shares at a deemed value of $0.02 each.
  • Approximately 1,000,000 common shares of Nelson Lake (the “Dividend Shares”) will be distributed to Lancaster shareholders at the Transaction's closing.
  • Lancaster Shareholders holding shares as of the Record Date will receive shares in Nelson Lake Copper Corp. in addition to shares held in Lancaster.

Lancaster Resources to Spin-Off Nelson Lake through Plan of Arrangement

Retrieved on: 
Tuesday, January 30, 2024

Full details of the Spin-Off, Nelson Lake, and the Nelson Lake Copper Project will be included in an information circular which will be distributed to Lancaster shareholders in advance of the Meeting.

Key Points: 
  • Full details of the Spin-Off, Nelson Lake, and the Nelson Lake Copper Project will be included in an information circular which will be distributed to Lancaster shareholders in advance of the Meeting.
  • Immediately after the Spin-Off, the Company will continue to own approximately 750,000 shares of Nelson Lake, which will be approximately 43% of the outstanding shares of Nelson Lake.
  • Pursuant to the Arrangement Agreement, the parties have agreed to a Plan of Arrangement whereby Lancaster will issue 550,000 Lancaster common shares with a deemed value of $0.06 each to Nelson Lake in exchange for 1,650,000 Nelson Lake shares at a deemed value of $0.02 each.
  • Lancaster Shareholders holding shares as of the Record Date will receive shares in Nelson Lake Copper Corp. in addition to shares held in Lancaster.

Avalon Appoints Veteran Renewables and Clean-Tech Executive to Board of Directors

Retrieved on: 
Wednesday, October 25, 2023

The appointment is effective October 24th, 2023, and further solidifies a revamped Board and Governance structure that will accelerate Avalon's corporate development.

Key Points: 
  • The appointment is effective October 24th, 2023, and further solidifies a revamped Board and Governance structure that will accelerate Avalon's corporate development.
  • We look forward to his contributions to the Board and Avalon's senior leadership team."
  • The executive successfully took an idea from lab patent in 2000 to a public company in 2010.
  • Avalon would also like to extend its sincere gratitude to John E. Fisher, who has stepped down from the Board of Directors.

AGE-WELL and SE Health launch new competition for startups, community-based and youth-serving organizations innovating to support older adults

Retrieved on: 
Thursday, March 23, 2023

From these applications, finalists will be chosen to pitch their solutions to a panel of expert judges at a live event on June 22, 2023.

Key Points: 
  • From these applications, finalists will be chosen to pitch their solutions to a panel of expert judges at a live event on June 22, 2023.
  • There are two separate application categories: 1) Startups (with a prototype, market-ready or looking to scale); and 2) Community-based or youth-serving organizations (ideation or scaling).
  • Finalists will compete in their respective category and will be challenged to explain how their solution can positively impact older Canadians or caregivers.
  • To apply or find out more about the National Impact Challenge 2023 – Bold Innovations for Living, please see the competition main page .

Capital Project Management, Inc. Announces New Leadership

Retrieved on: 
Wednesday, January 11, 2023

Mike will maintain a leadership role as a principal of the firm.

Key Points: 
  • Mike will maintain a leadership role as a principal of the firm.
  • “We’ve built a national company from the ground up with a best-in-class team and the infrastructure to support our continued growth,” he says.
  • “I am extremely confident in Rob’s ability to take CPMI to the next level.”
    Rob has been a principal of CPMI since 2014.
  • Founded in 1996, Capital Project Management, Inc. offers consulting and expert witness services to attorneys, owners, contractors, and other professionals engaged in capital construction projects and related litigation, worldwide.

Dundee Precious Metals Announces Life of Mine Plan with Additional Production and Updated Mineral Resource and Mineral Reserve Estimate for Ada Tepe

Retrieved on: 
Thursday, January 12, 2023

Estimates of Measured and Indicated Mineral Resources are reported exclusive of those Mineral Resources modified to produce Mineral Reserves.

Key Points: 
  • Estimates of Measured and Indicated Mineral Resources are reported exclusive of those Mineral Resources modified to produce Mineral Reserves.
  • CSA Global (UK) Ltd. (“CSA Global”) are not aware of any legal, political, environmental or other risk factors that might materially affect the estimate of Mineral Resources.
  • Mineral Resources are based on a gold-cut off grade of 0.6 g/t for the Upper Zone and Overburden and 0.8 g/t for the Wall Zone and Basement mineralization.
  • Readers are encouraged to read the technical report in its entirety, including all qualifications, assumptions, exclusions and risks that relate to the Mineral Resource, Mineral Reserves and LOM.

Spine BioPharma Announces First Patient Treated in U.S. Phase 3 Clinical Study

Retrieved on: 
Wednesday, September 7, 2022

NEW YORK, Sept. 7, 2022 /PRNewswire/ -- Spine BioPharma, Inc., a company committed to developing non-opiate, non-surgical therapies for the treatment of Chronic Low Back Pain (CLBP) and related disability caused by Degenerative Disc Disease (DDD), today announced the first patient treated in a Phase 3 clinical study of SB-01 For Injection (SB-01). The SB-01 Phase 3 study is known as the MODEL Study (Moderate – Severe Degenerative Disc Disease Evaluation of the Lumbar Spine). SB-01 is the first intradiscal pharmacologic treatment to enter Phase 3 studies for the treatment of pain-related disability, associated with DDD. 

Key Points: 
  • The SB-01 Phase 3 study is known as the MODEL Study (Moderate Severe Degenerative Disc Disease Evaluation of the Lumbar Spine).
  • SB-01 is the first intradiscal pharmacologic treatment to enter Phase 3 studies for the treatment of pain-related disability, associated with DDD.
  • The patient was treated at Conquest Research in Winter Park, FL where Dr. Malisa Agard is the Principal Investigator.
  • The Phase 3 study of SB-01 is being conducted at 30 investigational sites across the US, enrolling up to 400 patients (Clinicaltrials.gov: NCT05516992 ).

Mythic Therapeutics Announces Appointment of Gilles Gallant, BPharm PhD FOPQ as Chief Development Officer

Retrieved on: 
Tuesday, August 23, 2022

Mythic Therapeutics, a biotechnology company focused on the development of antibody-drug conjugate-based therapies for the treatment of a wide range of cancers, announced today the appointment of Gilles Gallant, BPharm, PhD, FOPQ, to the new position of Chief Development Officer.

Key Points: 
  • Mythic Therapeutics, a biotechnology company focused on the development of antibody-drug conjugate-based therapies for the treatment of a wide range of cancers, announced today the appointment of Gilles Gallant, BPharm, PhD, FOPQ, to the new position of Chief Development Officer.
  • The company also announced that Mythic co-founder and CEO Alex Nichols, PhD, has transitioned in order to pursue new opportunities.
  • View the full release here: https://www.businesswire.com/news/home/20220822005749/en/
    We are delighted to have Dr. Gallant join our team at Mythic, said Brian Fiske, PhD, Co-founder and Chief Scientific Officer.
  • As Chief Development Officer, Dr. Gallant is responsible for the strategy, direction, and execution of the companys clinical development program.

Estate Planners Globally Now Have a Comprehensive and Practical Client-Based Approach to Digital Estate Planning

Retrieved on: 
Wednesday, July 6, 2022

Through the Quadriga bankruptcy trustee case, the authors educate estate advisors on the legal and practical technical management considerations surrounding digital assets, including potential financial and emotional losses resulting from undisclosed or inaccessible digital assets.

Key Points: 
  • Through the Quadriga bankruptcy trustee case, the authors educate estate advisors on the legal and practical technical management considerations surrounding digital assets, including potential financial and emotional losses resulting from undisclosed or inaccessible digital assets.
  • The recent publication is the most in-depth guide yet to estate planning and the digital world.
  • Clients of estate planners will choose organizations that are technologically savvy and have the right processes and tools to address their digital and physical lives in estate planning.
  • Sharons first book, Your Digital Undertaker: Exploring Death in the Digital Age in Canada , examines digital assets in the context of an individuals or clients estate planning life cycle.

Alida Welcomes New Vice President of Corporate Development

Retrieved on: 
Monday, December 6, 2021

Alida, a visionary leader in Total Experience Management (TXM), today announced the appointment of Gaurav Bhide as Vice President of Corporate Development.

Key Points: 
  • Alida, a visionary leader in Total Experience Management (TXM), today announced the appointment of Gaurav Bhide as Vice President of Corporate Development.
  • Bhides extensive experience will strengthen and propel Alidas corporate development plans and M&A strategy, further instilling the organization as a leader in the Customer Experience Management (CXM) market.
  • View the full release here: https://www.businesswire.com/news/home/20211206005106/en/
    Gaurav Bhide joins Alida as Vice President, Corporate Development (Photo: Business Wire)
    Im thrilled to join the talented team here at Alida.
  • With his deep experience in corporate development, he will help to inform our strategic future M&A activity and initiatives, said Ross Wainwright, CEO at Alida.